Form D · Biotechnology
FP Technology
Mountain View, CA · CIK 0001497173
Offering snapshot reported Jul 28, 2010 · SEC filing
- Reported sold
- $825K Offering amount: $6.47M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 6, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2010 | Initial | $825,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-145562
Source: Form D, filed Jul 28, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Bogue | Executive |
| Declan Collins | Director |
| Josh Hogan | Director |
| Milt Mc Coll | Director |
| John Ryan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
897 Independence Avenue Suite 5 B
Mountain View, CA, 94043
Mountain View, CA, 94043